Perioperative low molecular weight heparin for infrageniculate bypass.

[1]  P. Bossuyt,et al.  Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. , 1996, The New England journal of medicine.

[2]  J. Hirsh,et al.  A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. , 1996, The New England journal of medicine.

[3]  V. Kakkar,et al.  Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting , 1994, The Lancet.

[4]  F. Piarulli,et al.  Clinical Assessment of Low Molecular Weight Heparin Effects in Peripheral Vascular Disease , 1993, Angiology.

[5]  M. Schemper,et al.  A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis. , 1992, Archives of Surgery.

[6]  G. Raskob,et al.  Optimal therapeutic level of heparin therapy in patients with venous thrombosis. , 1992, Archives of internal medicine.

[7]  M. Prins,et al.  Heparin Binding to Plasma Proteins, an Important Mechanism for Heparin Resistance , 1992, Thrombosis and Haemostasis.

[8]  W. Pearce,et al.  Long-term evaluation of composite sequential bypass for limb-threatening ischemia. , 1992, Journal of vascular surgery.

[9]  C. McCollum,et al.  Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. , 1991, Journal of vascular surgery.

[10]  T. Scherstén,et al.  Influence of coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgery. , 1990, American journal of surgery.

[11]  J. Cronenwett,et al.  Intragraft drug infusion as an adjunct to balloon catheter thrombectomy for salvage of thrombosed infragenicular vein grafts: a preliminary report. , 1990, Journal of vascular surgery.

[12]  B. Boneu,et al.  Pharmacokinetic Studies of Standard Unfractionated Heparin, and Low Molecular Weight Heparins in the Rabbit , 1988, Seminars in thrombosis and hemostasis.

[13]  P. Klein,et al.  Avoiding early failure of tibial prosthetic bypass grafts. , 1987, The Thoracic and cardiovascular surgeon.

[14]  D. Rosenthal,et al.  The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results. , 1987, The American surgeon.

[15]  M. Schemper,et al.  The influence of anticoagulant treatment on the probability of function in femoropopliteal vein bypass surgery: analysis of a clinical series (1970 to 1985) and interim evaluation of a controlled clinical trial. , 1987, Surgery.

[16]  J. S. Yao,et al.  Technical defects as a cause of early graft failure after femorodistal bypass. , 1987, Archives of surgery.

[17]  J. Webster,et al.  Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts , 1987, The British journal of surgery.

[18]  M. Schemper,et al.  Influence of anticoagulant treatment in preventing graft occlusion following saphenous vein bypass for femoropopliteal occlusive disease , 1986, The British journal of surgery.

[19]  V. Bernhard,et al.  Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. , 1986, Journal of vascular surgery.

[20]  A. Sterpetti,et al.  Seven-year experience with polytetrafluoroethylene as above-knee femoropopliteal bypass graft. Is is worthwhile to preserve the autologous saphenous vein? , 1985, Journal of vascular surgery.

[21]  M. Samama,et al.  Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration. , 1985, Thrombosis research.

[22]  B. Satiani.  A Prospective Randomized Trial of Aspirin in Femoral Popiteal and Tibial Bypass Grafts , 1985, Angiology.

[23]  R. Rutherford,et al.  The efficacy of dextran 40 in preventing early postoperative thrombosis following difficult lower extremity bypass. , 1984, Journal of vascular surgery.

[24]  M. Donaldson,et al.  Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts. , 1984, Surgery.

[25]  R. Green,et al.  Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency. , 1982, Surgery.

[26]  C. Mattsson,et al.  Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits. , 1982, Thrombosis research.

[27]  A. Clowes,et al.  Secondary femoropopliteal reconstruction. , 1981, Annals of surgery.